PETRUS JOHANNES LOUIS SPEE

Person

ALLEROED, DK

People

Patents Grantslast 30 patents

Information Patent Grant
KIR-binding agents and methods of use thereof
- Patent number 9,708,403
- Issue date Jul 18, 2017
- NOVO NORDISK A/S
- Søren Berg Padkær
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-NKG2A antibodies and uses thereof
- Patent number 9,683,041
- Issue date Jun 20, 2017
- Novo Nordisk A/S
- Petrus Johannes Louis Spee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating proliferative disorders
- Patent number 9,447,185
- Issue date Sep 20, 2016
- Innate Pharma, S.A.
- Francois Romagne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-human NKG2A monoclonal antibody
- Patent number 9,422,368
- Issue date Aug 23, 2016
- Novo Nordisk A/S
- Petrus Johannes Louis Spee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
LLT-1 antibodies with new functional properties
- Patent number 9,376,496
- Issue date Jun 28, 2016
- Centre National de la Recherche Scientifique
- Petrus Johannes Louis Spee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
LLT-1 antibodies with new functional properties
- Patent number 9,127,052
- Issue date Sep 8, 2015
- Centre National de la Recherche Scientifique
- Petrus Johannes Louis Spee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-NKG2A antibodies and uses thereof
- Patent number 8,901,283
- Issue date Dec 2, 2014
- Novo Nordisk A/S
- Petrus Johannes Louis Spee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-human NKG2A monoclonal antibody
- Patent number 8,796,427
- Issue date Aug 5, 2014
- Novo Nordisk A/S
- Petrus Johannes Louis Spee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding human anti-kir antibodies
- Patent number 8,614,307
- Issue date Dec 24, 2013
- Novo-Nordisk A/S—Novo Alle
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20190248896
- Publication date Aug 15, 2019
- Novo Nordisk A/S
- PETRUS JOHANNES LOUIS SPEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20170281809
- Publication date Oct 5, 2017
- Novo Nordisk A/S
- PETRUS JOHANNES LOUIS SPEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LLT-1 ANTIBODIES WITH NEW FUNCTIONAL PROPERTIES
- Publication number 20160024215
- Publication date Jan 28, 2016
- Centre National de la Recherche Scientifique
- Petrus Johannes Louis SPEE
- G01 - MEASURING TESTING
Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20150071929
- Publication date Mar 12, 2015
- Novo Nordisk A/S
- PETRUS JOHANNES LOUIS SPEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-HUMAN NKG2A MONOCLONAL ANTIBODY
- Publication number 20140341896
- Publication date Nov 20, 2014
- PETRUS JOHANNES LOUIS SPEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LLT-1 ANTIBODIES WITH NEW FUNCTIONAL PROPERTIES
- Publication number 20130164299
- Publication date Jun 27, 2013
- CNRS
- Petrus Johannes Louis Spee
- G01 - MEASURING TESTING

PETRUS JOHANNES LOUIS SPEE

Person

Patents Grantslast 30 patents

KIR-binding agents and methods of use thereof

Anti-NKG2A antibodies and uses thereof

Compositions and methods for treating proliferative disorders

Humanized anti-human NKG2A monoclonal antibody

LLT-1 antibodies with new functional properties

LLT-1 antibodies with new functional properties

Anti-NKG2A antibodies and uses thereof

Humanized anti-human NKG2A monoclonal antibody

Nucleic acids encoding human anti-kir antibodies

Patents Applicationslast 30 patents

ANTI-NKG2A ANTIBODIES AND USES THEREOF

ANTI-NKG2A ANTIBODIES AND USES THEREOF

LLT-1 ANTIBODIES WITH NEW FUNCTIONAL PROPERTIES

ANTI-NKG2A ANTIBODIES AND USES THEREOF

HUMANIZED ANTI-HUMAN NKG2A MONOCLONAL ANTIBODY

LLT-1 ANTIBODIES WITH NEW FUNCTIONAL PROPERTIES